President Trump's pronouncement that pregnant women should avoid Tylenol overshadowed another important health headline. The FDA is in the process of approving a medication called leucovorin to treat some symptoms of autism.
Breakdown
- The FDA is reviewing leucovorin, a cancer drug, for autism treatment. 8s
- Leucovorin is a generic drug derived from folic acid and has been used off-label for autism. 1m 19s
- Some children with autism reportedly show improved speech after taking leucovorin. 1m 44s
- The FDA's review is proceeding despite a lack of large phase three clinical trials. 2m 7s
- Experts and organizations call for more research before recommending leucovorin widely. 2m 23s